Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-18
Closed -$258 1225
2020
Q4
$258 Buy
+18
New +$211 ﹤0.01% 1129
2020
Q1
Sell
-2,291
Closed -$53.7K 1079
2019
Q4
$53.7K Sell
2,291
-123
-5% -$2.63K ﹤0.01% 438
2019
Q3
$55.5K Sell
2,414
-295
-11% -$6.75K 0.01% 423
2019
Q2
$69.5K Hold
2,709
0.01% 402
2019
Q1
$98.1K Hold
2,709
0.01% 329
2018
Q4
$78.3K Hold
2,709
0.01% 350
2018
Q3
$178K Sell
2,709
-495
-15% -$32.1K 0.02% 265
2018
Q2
$209K Hold
3,204
0.02% 240
2018
Q1
$176K Hold
3,204
0.02% 263
2017
Q4
$214K Buy
3,204
+331
+12% +$19.5K 0.03% 238
2017
Q3
$169K Buy
+2,873
New +$140K 0.02% 269

Other funds holding OVV

RBC Europe's OVV Position: Q1 2021 in Review

RBC Europe sold out of Ovintiv (OVV) in Q1 2021, closing a stake of 18 shares — an estimated $258 sold.

RBC Europe first reported a position in OVV in Q3 2017 and held it in 11 quarters. The position peaked at $214K in Q4 2017. 292 funds tracked by Wall St. Rank hold OVV as of Q1 2021.

  • RBC Europe reported no remaining Ovintiv position as of Q1 2021 after selling out during the quarter.
  • RBC Europe sold 18 Ovintiv shares in Q1 2021, an estimated $258.
  • RBC Europe first reported a position in Ovintiv in Q3 2017 and held it in 11 quarters.
  • RBC Europe's Ovintiv position peaked at $214K in Q4 2017.
  • 292 funds tracked by Wall St. Rank held Ovintiv as of Q1 2021.

Based on RBC Europe's 13F filing for Q1 2021, filed 9 Nov 2023.